IMPACT OF INTRAPARTUM CHEMOPROPHYLAXIS ON NEONATAL SEPSIS

This publication has 12 references indexed in Scilit:

• Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis
  The Lancet Infectious Diseases, 2003
• Antepartum use of antibiotics and early-onset neonatal sepsis: The next 4 years
  American Journal of Obstetrics and Gynecology, 2002
• A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates
  New England Journal of Medicine, 2002
• Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants
  New England Journal of Medicine, 2002
• The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease
  American Journal of Obstetrics and Gynecology, 2001
• Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
  New England Journal of Medicine, 2000
• Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control Study
  Pediatrics, 2000
• Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia
  The Pediatric Infectious Disease Journal, 1999
• Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis
  Infectious Diseases in Obstetrics and Gynecology, 1999
• Neonatal Early-Onset Escherichia coli Disease
  Archives of Pediatrics & Adolescent Medicine, 1998